Jeffrey D. Abbey serves as Executive at ARGOS THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Jeffrey D. Abbey has executed 18 insider transactions totaling $135.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 25, 2018 involved selling 67,887 shares valued at $0.
Jeffrey D. Abbey currently holds 25,450 shares of ARGOS THERAPEUTICS INC (ARGS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey D. Abbey has been a net seller of ARGS stock. They have purchased $59.1K and sold $76.7K worth of shares.
Jeffrey D. Abbey's most recent insider trade was on Apr 25, 2018, when they sold 67,887 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 10, 2018 | ARGS | $20.0K | Sale | 124,987 | $0.16 | Discretionary |
| Jan 9, 2018 | ARGS | $20.0K | Sale | 124,987 | $0.16 | Discretionary |
| Jan 3, 2018 | ARGS | $18.4K | Sale | 114,702 | $0.16 | Discretionary |
| Jan 3, 2018 | ARGS | $18.4K | Sale | 114,702 | $0.16 | Discretionary |
| Aug 30, 2017 | ARGS | $0 | Award | 622,685 | $N/A | Discretionary |
| Jan 19, 2017 | ARGS | $0 | Award | 17,430 | $N/A | Discretionary |
| Jun 13, 2016 | ARGS | $0 | Award | 10,924 | $N/A | Discretionary |
| Jan 8, 2016 | ARGS | $0 | Award | 90,401 | $N/A | Discretionary |
| Dec 14, 2015 | ARGS | $12.5K | Purchase | 5,000 | $2.50 | Discretionary |
| Dec 14, 2015 | ARGS | $12.5K | Purchase | 5,000 | $2.50 | Discretionary |
| Dec 2, 2015 | ARGS | $3.9K | Purchase | 1,000 | $3.89 | Discretionary |
| Nov 19, 2015 | ARGS | $4.1K | Purchase | 1,000 | $4.08 | Discretionary |
| Aug 19, 2015 | ARGS | $26.1K | Purchase | 5,500 | $4.75 | Discretionary |
| Feb 12, 2014 | ARGS | $0 | Conversion | 1,267 | $N/A | Discretionary |
| Feb 12, 2014 | ARGS | $0 | Conversion | 1,238 | $N/A | Discretionary |
| Feb 12, 2014 | ARGS | $0 | Conversion | 75 | $N/A | Discretionary |